San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

Cold Wallet’s progress is accelerating, securing $5.9 million in its presale while holding a sharp 4,900% return potential ...

Litecoin ETF approval talk grows as institutional interest rises, fueled by regulatory clarity and LTC’s increasing role in ...

Unilabs Finance (UNIL), and Hedera (HBAR) are emerging as strong contenders in the crypto space. These underrated coins could ...

Follow Cold Wallet’s $5.9M presale growth backed by real users and cashback utility, while the Litecoin (LTC) price surge ...

Over the past month, the crypto market has been on fire — and two big names, Litecoin and XRP, have been leading the charge.

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional ...

In other recent news, MEI Pharma, Inc. has announced a significant financial strategy shift involving a $100 million private placement aimed at establishing a Litecoin treasury reserve.

MEI Pharma (MEIP) shares soared Friday premarket as it unveiled a $100 million private placement to fund its new Litecoin treasury strategy, marking a groundbreaking shift in corporate crypto ...